Bacterial Pneumonia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Condition: Bacterial PneumoniaInterventions: Drug: Imipenem; Drug: Relebactam; Drug: Cilastatin; Drug: Piperacillin; Drug: Tazobactam; Drug: LinezolidSponsor: Merck Sharp & Dohme Corp.Not yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2015 Category: Research Source Type: clinical trials
